Related references
Note: Only part of the references are listed.Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis
Maria-Eleni Androutsou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions
Anastasia Dagkonaki et al.
FRONTIERS IN IMMUNOLOGY (2020)
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes
Sebastian M. Heimburger et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease
Giuseppe Cappellano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Design, synthesis and evaluation of an anthraquinone derivative conjugated to myelin basic protein immunodominant (MBP85-99) epitope: Towards selective immunosuppression
Anthi Tapeinou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87-99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis
Mary Emmanouil et al.
MOLECULES (2018)
Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance
Robert Kuo et al.
MOLECULAR THERAPY (2017)
In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance
Ryan M. Pearson et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity
Leonard Moise et al.
EXPERT REVIEW OF VACCINES (2016)
Molecular dynamics at the receptor level of immunodominant myelin oligodendrocyte glycoprotein 35-55 epitope implicated in multiple sclerosis
Mary Patricia Yannakakis et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2016)
Advances in Fmoc solid-phase peptide synthesis
Raymond Behrendt et al.
JOURNAL OF PEPTIDE SCIENCE (2016)
Conjugation of a peptide to mannan and its confirmation by tricine sodium dodecyl sulfate-polyacrylamide gel electrophoresis
Anthi Tapeinou et al.
ANALYTICAL BIOCHEMISTRY (2015)
Advances in the immunopathogenesis of multiple sclerosis
Sudhir K. Yadav et al.
CURRENT OPINION IN NEUROLOGY (2015)
Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis
Vivian Tseveleki et al.
EXPERIMENTAL NEUROLOGY (2015)
Mannosylated linear and cyclic single amino acid mutant peptides using a small 10 amino acid linker constitute promising candidates against multiple sclerosis
Stephanie Day et al.
FRONTIERS IN IMMUNOLOGY (2015)
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
Alberto Gajofatto et al.
WORLD JOURNAL OF CLINICAL CASES (2015)
Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35-55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice
Theodore Tselios et al.
MOLECULES (2014)
Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles
Daniel R. Getts et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis
Giuseppe Cappellano et al.
VACCINE (2014)
Multiple Sclerosis: Prospects and Promise
Stephen L. Hauser et al.
ANNALS OF NEUROLOGY (2013)
The Future of Peptide-based Drugs
David J. Craik et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
The role of dendritic cells in autoimmunity
Dipyaman Ganguly et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Decisions About Dendritic Cells: Past, Present, and Future
Ralph M. Steinman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
C-type lectin receptors and cytokines in fungal immunity
Simon Vautier et al.
CYTOKINE (2012)
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE
Magnus Isaksson et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Dendritic Cells Ameliorate Autoimmunity in the CNS by Controlling the Homeostasis of PD-1 Receptor+ Regulatory T Cells
Nir Yogev et al.
IMMUNITY (2012)
Targeting tumor antigens to dendritic cells using particulate carriers
Medha D. Joshi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis
Daniel R. Getts et al.
NATURE BIOTECHNOLOGY (2012)
Protein Native-State Stabilization by Placing Aromatic Side Chains in N-Glycosylated Reverse Turns
Elizabeth K. Culyba et al.
SCIENCE (2011)
Altered peptide ligands of myelin basic protein (MBP87-99) conjugated to reduced mannan modulate immune responses in mice
Maria Katsara et al.
IMMUNOLOGY (2009)
Therapeutic application of peptides and proteins: parenteral forever?
Zuzana Antosova et al.
TRENDS IN BIOTECHNOLOGY (2009)
Influence of Ligand Valency on the Targeting of Immature Human Dendritic Cells by Mannosylated Liposomes
Socorro Espuelas et al.
BIOCONJUGATE CHEMISTRY (2008)
Poly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins
Laura J. Peek et al.
LANGMUIR (2008)
Glatiramer acetate: Mechanisms of action in multiple sclerosis
Wiebke Schrempf et al.
AUTOIMMUNITY REVIEWS (2007)
Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis
Junda Kel et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Comparison of proposed putative active conformations of myelin basic protein epitope 87-99 linear altered peptide ligands by spectroscopic and modelling studies: The role of positions 91 and 96 in T-cell receptor activation
Efthimia D. Mantzourani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses
M. E. Christine Lutsiak et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Structural requirements for binding of Myelin Basic Protein (MBP) peptides to MHC II: Effects on immune regulation
ED Mantzourani et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Polymer microspheres for controlled drug release
S Freiberg et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain
MS Windrem et al.
NATURE MEDICINE (2004)
The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis
CS Clements et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Characterization of sugar binding by the mannose receptor family member, Endo180
L East et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cutting edge:: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis
AP Kohm et al.
JOURNAL OF IMMUNOLOGY (2002)
The mannose receptor family
L East et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
CNS myelinogenesis in vitro:: Myelin basic protein deficient shiverer oligodendrocytes
C Seiwa et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Share Paper
